HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

NADPH

HCID 5884
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
53-57-6
Standard SMILES
NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1
InChIKey
ACFIXJIJDZMPPO-NNYOXOHSSA-N
Molecular formula
C21H30N7O17P3
Average molar mass
745.4 g/mol
Monoisotopic mass
745.09110351

Overview

NADPH is the reduced form of NADP+; used in anabolic reactions, such as lipid and nucleic acid synthesis, which require NADPH as a reducing agent. It has a role as a cofactor and a fundamental metabolite. It is a NAD(P)H and a NADP. It is a conjugate acid of a NADPH(4-).

Names & identifiers

Preferred name
NADPH
IUPAC
[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
English name
NADPH
Molecular formula
C21H30N7O17P3
Molecular weight
745.42

Names & synonyms

NADPH53-57-6TPNHDihydronicotinamide-adenine dinucleotide phosphateDihydrocodehydrogenase II2646-71-1Reduced triphosphopyridine nucleotideReduced Nicotinamide Adenine Dinucleotide PhosphateNADPH2beta-NADPHMFCD00674870381Q4X082D
Show more names
reducedNADPNNa4 saltent-NADPHβ-NADPH-d4NADPH ≥98%Reduced Co IITriphosphopyridine Nu
dihydronicotinamide adenine dinucleotide phosphatereduced nicotinamide-adenine dinucleotide phosphate[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphateNicotinamide-adenine dinucleotide phosphate, reducedAdenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamidereduced Coenzyme IIMFCD00036263dihydronicotinamide adenine dinucleotide-P

Database identifiers

CAS
53-57-6

Properties

Computed structural properties

XLogP
-6.8
Topological polar surface area
364 Ų
Hydrogen bond donors
9
Hydrogen bond acceptors
22
Rotatable bonds
13
Heavy atoms
48
Formal charge
0
Complexity
1,410

Experimental & physicochemical properties

Chemical ClassesBiological Agents -> Other Biomolecules
DrugsPharmaceuticals -> Listed in ZINC15
Physical DescriptionSolid
Collision Cross Section · 2 items

232.2 Ų [M]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

232.4 Ų [M+H]+

Physicochemical properties

Boiling point
1175.1 · 1175.1±75.0 °C(Predicted)
Density
2.28 · 2.28±0.1 g/cm3(Predicted)
pka
1.13 · 1.13±0.50(Predicted)
form
Solid
color
White to light yellow
FDA UNII
381 Q4X082D · 381Q4X082D
EPA Substance Registry System
Nicotinamide adenine dinucleotide phosphate (53-57-6)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Regulatory InformationAdenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'→5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide: Does not have an individual approval but may be used under an appropriate group standard
Hazards SummarySee NADP.

Safety data

tsca
TSCA listed

Chemistry & industry

Pharmacology

Tissue LocationsAll Tissues
Cellular LocationsCytoplasm
Metabolite Pathways11-beta-hydroxylase deficiency (CYP11B1)

Uses & manufacturing

UsesThe reduced form of NADP found in living cells; [Merck Index]
General Manufacturing InformationAdenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide: INACTIVE
Applications · 2 items

Usesβ-NADPH-d4 is the isotope labelled analog of β-NADPH. One of the biologically active forms of nicotinic acid. Differs from NAD by an additional phosphate group at the 2’-position of the adenosine moiety. Serves as a coenzyme of hydrogenases and dehydrogenases. Present in living cells primarily in the reduced form (NADPH) and is involved in synthetic reactions.

UsesOne of the biologically active forms of nicotinic acid. Differs from NAD by an additional phosphate group at the 2position of the adenosine moiety. Serves as a coenzyme of hydrogenases and dehydrogenases. Present in living cells primarily in the r

Upstream & downstream products

Upstream raw materials

i-Propylcyclopentadienylrhenium tricarbonyldihydrodiphosphopyridine nucleotide

Related reactions

113 records
New reaction record
HRID 6600 reaction equation
HRID 6600As reactant
HRID 14363 reaction equation
HRID 14363As reactant
HRID 20720 reaction equation
HRID 20720As reactant
HRID 20721 reaction equation
HRID 20721As reactant
HRID 215703 reaction equation
HRID 215703As reactant
HRID 223250 reaction equation
HRID 223250As product
HRID 256804 reaction equation
HRID 256804As product
HRID 263388 reaction equation
HRID 263388As product
PreviousPage 1 of 15

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
5884
DTXSID
DTXSID001018921
ChEMBL
CHEMBL407009
ChEBI
CHEBI:16474
UNII
381Q4X082D
EC Number
200-177-6
Nikkaji
J213.537J
TSCA
TSCA listed
β-Nicotinamide adenine dinucleotide
β-Nicotinamide Mononucleotide
Triphosphopyridine nucleotide
Adenosine triphosphate

Downstream products

5-amino-2,5-dioxo-pentanoic acid
Additional notes · 1 item

DefinitionA coenzyme composed of ribosylnicotinamide 5′- phosphate coupled by pyrophosphate linkage to the 5′-phosphate adenosine 2′,5′-bisphosphate. The reduced from of NADP. It is an energy-storage form that can be transferred to the Calvin cycle where it participates in the production of carbohydrate.